Clinical trials are not as terrifying as you think

阅读: 10

In the United States, clinical trials have gradually matured and are being used as one of the treatment options by an increasing number of patients. Some cancer patients see clinical trials as a hope for treatment, but there are also many misunderstandings about clinical trials. Among them, most people have relatively little understanding of clinical trials. Many patients miss out on opportunities due to misunderstandings about clinical trials.
Myth 1: Participating in clinical trials won't be very helpful to me
In fact, for patients, participating in clinical trials is an opportunity to access the latest therapies, and may even become a turning point in their fate.
For example, cancer patients can receive the latest anti-cancer drugs in the medical industry as soon as possible and receive free medication. For patients who have no hope in the final stage, the new drug may completely change their condition. For people suffering from chronic diseases, long-term medication without improvement, or even lingering side effects, new drugs may reverse the situation.
However, it is undeniable that there is still uncertainty about the experimental drug, so it is necessary to determine whether to try it after understanding its benefits and risks.

 

 

Myth 2: I will be treated as a 'little white mouse'
Most Chinese people refuse clinical trials simply because they do not want to be 'mice'. In fact, there is not much difference between clinical trials and regular treatment in terms of form. Instead, patients will receive better care: using the most advanced drugs, receiving the best examinations, and being treated by a high-level professional medical team, constantly monitoring the patient's physical condition. At the same time, researchers will make adjustments to the treatment at any time based on the patient's physical reactions, in order to achieve the best treatment effect.
The drugs used in clinical trials are only applied in the human body after years of rigorous testing and multiple trials; It will be decided whether to approve the listing after three stages of testing. Patients can choose to participate in any phase of the trial. In the first phase of clinical trials, participants will start using the minimum dose, while in the second and third phases of trials, the safety of the new drug has been basically guaranteed.
At the same time, clinical trials are strictly supervised by the Ethics Review Board (IRB), the China Foods Limited and Drug Administration (CFDA) and other institutions. Before participating in the experiment, the experimenter will explain in detail the potential benefits and side effects of the experiment, and then the patient will decide whether to participate. Even if participating in the experiment, one can withdraw at any time.

分享

推荐文章

  • Top